Ticker Details
Fulcrum Therapeutics, Inc.
IPO Date:	July 15, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$289.93M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.41 | 4.39%
Avg Daily Range (30 D):	$0.08 | 2.23%
Avg Daily Range (90 D):	$0.14 | 2.89%

Institutional Daily Volume
Avg Daily Volume:	.74M
Avg Daily Volume (30 D):	1.48M
Avg Daily Volume (90 D):	2.01M

Trade Size
Avg Trade Size (Sh.):	109
Avg Trade Size (Sh.) (30 D):	156
Avg Trade Size (Sh.) (90 D):	171

Institutional Trades
Total Institutional Trades:	954
Avg Institutional Trade:	$1.43M
Avg Institutional Trade (30 D):	$.83M
Avg Institutional Trade (90 D):	$1.1M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.47M
Avg Closing Trade (30 D):	$.81M
Avg Closing Trade (90 D):	$1.04M
Avg Closing Volume:	183.38K

News

Jun 2, 2026 @ 4:56 PM Fulcrum Therapeutics, Inc. Shareholders Are Encour... Source: Johnson Fistel, Pllp

Jun 2, 2026 @ 5:50 AM FULC Stock Crashes After Hours: What Investors Nee... Source: Tanya Rawat

Apr 27, 2026 @ 11:00 AM Fulcrum Therapeutics Announces Recent Business Hig... Source: Not Specified

Mar 19, 2026 @ 12:00 PM MedicAlert Foundation, Sickle Cell Disease Associa... Source: Na

Feb 24, 2026 @ 12:00 PM Fulcrum Therapeutics Announces Positive 12-Week Re... Source: Na

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS		$-.34	$-.25
Diluted EPS		$-.34	$-.25
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-26.18M	$-18.89M
Operating Income / Loss		$-29.31M	$-22.19M
Cost of Revenue
Net Cash Flow		$-1.9M	$-147.27M
PE Ratio